Archives: December 2016

The 21st Century Cures Act: How will it impact today’s biggest pharma challenges?

Congress recently passed the 21st Century Cures Act with $4.8 billion dollars in funding and a purpose of speeding the development and approval of new medicines and medical devices.  The act has generated significant excitement and discussion.  Some of the key components of the legislation include: $4.8 billion dollars additional...

Read More

Transformation Strategy in the Face of Uncertainty: Planning for a Future that Thrives

This fall, TayganPoint hosted its annual Forum with three spectacular contributors, including Bob McMahon (Merck & Co.); Ricci Whitlow (G&W Laboratories) and Angela Johnson (Johnson & Johnson). Our esteemed speakers joined us for a lively discussion about planning for a future that thrives while living through the ups and downs...

Read More

TayganPoint is Proud to be Re-Certified by WBENC as a Women Owned Business

TayganPoint Consulting Group was recently re-certified as a woman owned business by the Women’s Business Enterprise National Council (WBENC). This is the 10th successive year of affiliation for TayganPoint.  WBENC, founded in 1997, is the nation’s leading advocate of women-owned businesses as suppliers to America’s corporations. It is the largest third-party certifier of businesses...

Read More

Archives